565 related articles for article (PubMed ID: 26881039)
1. Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases.
Chiurchiù V; Orlacchio A; Maccarrone M
Oxid Med Cell Longev; 2016; 2016():7909380. PubMed ID: 26881039
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
3. Chemistry and biochemistry of oxidative stress in neurodegenerative disease.
Sayre LM; Smith MA; Perry G
Curr Med Chem; 2001 Jun; 8(7):721-38. PubMed ID: 11375746
[TBL] [Abstract][Full Text] [Related]
4. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
[TBL] [Abstract][Full Text] [Related]
5. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
Singh A; Kukreti R; Saso L; Kukreti S
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
7. The role of metals in neurodegenerative diseases.
Sayre LM; Perry G; Atwood CS; Smith MA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):731-41. PubMed ID: 10875436
[TBL] [Abstract][Full Text] [Related]
8. Metal ions and oxidative protein modification in neurological disease.
Sayre LM; Moreira PI; Smith MA; Perry G
Ann Ist Super Sanita; 2005; 41(2):143-64. PubMed ID: 16244388
[TBL] [Abstract][Full Text] [Related]
9. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
10. RNA oxidation in Alzheimer disease and related neurodegenerative disorders.
Nunomura A; Hofer T; Moreira PI; Castellani RJ; Smith MA; Perry G
Acta Neuropathol; 2009 Jul; 118(1):151-66. PubMed ID: 19271225
[TBL] [Abstract][Full Text] [Related]
11. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
Polidori MC; Griffiths HR; Mariani E; Mecocci P
Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
[TBL] [Abstract][Full Text] [Related]
12. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
van Muiswinkel FL; Kuiperij HB
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
[TBL] [Abstract][Full Text] [Related]
13. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
Mattson MP
Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
[TBL] [Abstract][Full Text] [Related]
14. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes.
Calabrese V; Guagliano E; Sapienza M; Panebianco M; Calafato S; Puleo E; Pennisi G; Mancuso C; Butterfield DA; Stella AG
Neurochem Res; 2007; 32(4-5):757-73. PubMed ID: 17191135
[TBL] [Abstract][Full Text] [Related]
15. Peripheral markers of oxidative stress and excitotoxicity in neurodegenerative disorders: tools for diagnosis and therapy?
Facheris M; Beretta S; Ferrarese C
J Alzheimers Dis; 2004 Apr; 6(2):177-84. PubMed ID: 15096702
[TBL] [Abstract][Full Text] [Related]
16. Redox-sensitive GFP to monitor oxidative stress in neurodegenerative diseases.
Esposito S; Masala A; Sanna S; Rassu M; Pimxayvong V; Iaccarino C; Crosio C
Rev Neurosci; 2017 Feb; 28(2):133-144. PubMed ID: 28030361
[TBL] [Abstract][Full Text] [Related]
17. Medical hypothesis: Neurodegenerative diseases arise from oxidative damage to electron tunneling proteins in mitochondria.
Bennett JP
Med Hypotheses; 2019 Jun; 127():1-4. PubMed ID: 31088629
[TBL] [Abstract][Full Text] [Related]
18. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
19. [Free radical processes in aging, neurodegenerative diseases and other pathological states].
Dubinina EE; Pustygina AV
Biomed Khim; 2007; 53(4):351-72. PubMed ID: 18035718
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in neurodegenerative disease: causation or association?
Van Raamsdonk JM; Vega IE; Brundin P
Oncotarget; 2017 Feb; 8(7):10777-10778. PubMed ID: 28099897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
